EvogeneEVGN
13F holders, Q1 2025 (March 31)16holders +1
3new positions
3sold out
$1.25avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Evogene Ltd. (EVGN) in their 13F filings, up 1 from Q4 2024. 3 opened new positions and 3 sold out. The largest holders were Armistice Capital, LLC ($395K), Jane Street Group, LLC ($42K) and UBS Group AG ($23K).
- Company
- Evogene Ltd.
- CUSIP
- M4119S187
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $13K |
| Exits | 3 | $30K |
All 13F filers, Q4 2024 → Q1 2025: 42,840 shares bought and 23,489 shares sold, net +19,351 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Armistice Capital, LLC | 0.01% | Add +6.0% | 316,024 | $395K |
| Jane Street Group, LLC | 0.00% | Add +58.0% | 33,732 | $42K |
| UBS Group AG | 0.00% | Reduce -14.8% | 18,745 | $23K |
| Morgan Stanley | 0.00% | No change | 14,586 | $18K |
| Two Sigma Securities, LLC | 0.00% | Add +21.5% | 13,562 | $17K |
| BNP Paribas Financial Markets | 0.00% | No change | 12,819 | $16K |
| XTX Topco Ltd | 0.00% | New | 10,179 | $13K |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +1.0% | 505 | $631 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 500 | $625 |
| Osaic Holdings, Inc. | 0.00% | Reduce -64.8% | 190 | $242 |
| JPMorgan Chase & Co. | 0.00% | Reduce -95.2% | 200 | $114 |
| Bank of America Corp. | 0.00% | Add +1300.0% | 84 | $105 |
| SBI Securities Co., Ltd. | 0.00% | No change | 72 | $90 |
| Tidemark, LLC | 0.00% | New | 30 | $38 |
| US Bancorp \de | 0.00% | New | 15 | $19 |
| Royal Bank of Canada | 0.00% | No change | 42 | $0 |
"% of holder's portfolio" is EVGN's weight in each manager's 13F, not the share of Evogene Ltd. the manager owns.